Cell adhesion molecules and eNOS expression in aorta of normocholesterolemic mice with different predispositions to atherosclerosis

Heart and Vessels

Volumn 30, Issue 2, 2015, Pages 241-248

  Rathouska, Jana ^a   Nemeckova, Ivana ^a   Zemankova, Lenka ^a   Strasky, Zbynek ^a   Jezkova, Katerina ^a   Varejckova, Michala ^a   Nachtigal, Petr ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

C3H HeJ mice; C57BL 6J mice; Cell adhesion molecules; Endoglin; eNOS

Indexed keywords

AUTACOID; CELL ADHESION MOLECULE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, MOUSE;

ANIMAL; AORTA; ATHEROSCLEROSIS; C3H MOUSE; C57BL MOUSE; COMPARATIVE STUDY; ENZYMOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PHENOTYPE; PROTECTION; RISK FACTOR; SPECIES DIFFERENCE;

ANIMALS; AORTA; ATHEROSCLEROSIS; CELL ADHESION MOLECULES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; INFLAMMATION MEDIATORS; MICE, INBRED C3H; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE III; PHENOTYPE; PROTECTIVE FACTORS; RISK FACTORS; SPECIES SPECIFICITY;

EID: 84933532252     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-014-0493-8     Document Type: Article

References (32)

1. Paigen B, Ishida BY, Verstuyft J, Winters RB, Albee D (1990) Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis 10:316–323
2. Paigen B, Mitchell D, Reue K, Morrow A, Lusis AJ, LeBoeuf RC (1987) Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc Natl Acad Sci USA 84:3763–3767
3. Paigen B, Albee D, Holmes PA, Mitchell D (1987) Genetic analysis of murine strains C57BL/6J and C3H/HeJ to confirm the map position of Ath-1, a gene determining atherosclerosis susceptibility. Biochem Genet 25:501–511
4. Ishida BY, Blanche PJ, Nichols AV, Yashar M, Paigen B (1991) Effects of atherogenic diet consumption on lipoproteins in mouse strains C57BL/6 and C3H. J Lipid Res 32:559–568
5. Miyoshi T, Tian J, Matsumoto AH, Shi W (2006) Differential response of vascular smooth muscle cells to oxidized LDL in mouse strains with different atherosclerosis susceptibility. Atherosclerosis 189:99–105
6. Shi W, Pei H, Fischer JJ, James JC, Angle JF, Matsumoto AH, Helm GA, Sarembock IJ (2004) Neointimal formation in two apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility. J Lipid Res 45:2008–2014
7. Shi W, Wang NJ, Shih DM, Sun VZ, Wang X, Lusis AJ (2000) Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism. Circ Res 86:1078–1084
8. Galkina E, Ley K (2007) Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 27:2292–2301
9. Ley K, Huo Y (2001) VCAM-1 is critical in atherosclerosis. J Clin Invest 107:1209–1210
10. Ramos CL, Huo Y, Jung U, Ghosh S, Manka DR, Sarembock IJ, Ley K (1999) Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res 84:1237–1244
11. Walpola PL, Gotlieb AI, Cybulsky MI, Langille BL (1995) Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress. Arterioscler Thromb Vasc Biol 15:2–10
12. Ma X, Labinaz M, Goldstein J, Miller H, Keon WJ, Letarte M, O’Brien E (2000) Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration. Arterioscler Thromb Vasc Biol 20:2546–2552
13. Lopez-Novoa JM, Bernabeu C (2010) The physiological role of endoglin in the cardiovascular system. Am J Physiol Heart Circ Physiol 299:H959–H974
14. Ikemoto T, Hojo Y, Kondo H, Takahashi N, Hirose M, Nishimura Y, Katsuki T, Shimada K, Kario K (2011) Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases. Heart Vessels 27:344–351
15. Nachtigal P, Zemankova Vecerova L, Rathouska J, Strasky Z (2012) The role of endoglin in atherosclerosis. Atherosclerosis 224:4–11
16. Lastres P, Letamendia A, Zhang H, Rius C, Almendro N, Raab U, Lopez LA, Langa C, Fabra A, Letarte M, Bernabeu C (1996) Endoglin modulates cellular responses to TGF-beta 1. J Cell Biol 133:1109–1121
17. Toporsian M, Gros R, Kabir MG, Vera S, Govindaraju K, Eidelman DH, Husain M, Letarte M (2005) A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 96:684–692
18. Jerkic M, Rivas-Elena JV, Prieto M, Carron R, Sanz-Rodriguez F, Perez-Barriocanal F, Rodriguez-Barbero A, Bernabeu C, Lopez-Novoa JM (2004) Endoglin regulates nitric oxide-dependent vasodilatation. FASEB J 18:609–611
19. Vasquez R, Farias M, Vega JL, Martin RS, Vecchiola A, Casanello P, Sobrevia L (2007) d-glucose stimulation of l-arginine transport and nitric oxide synthesis results from activation of mitogen-activated protein kinases p42/44 and Smad2 requiring functional type II TGF-beta receptors in human umbilical vein endothelium. J Cell Physiol 212:626–632
20. Vecerova L, Strasky Z, Rathouska J, Slanarova M, Brcakova E, Micuda S, Nachtigal P (2012) Activation of TGF-beta receptors and Smad proteins by atorvastatin is related to reduced atherogenesis in ApoE/LDLR double knockout mice. J Atheroscler Thromb 19:115–126
21. Rathouska J, Vecerova L, Strasky Z, Slanarova M, Brcakova E, Mullerova Z, Andrys C, Micuda S, Nachtigal P (2011) Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis. Pharmacol Res 64:53–59
22. Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939–1951
23. Brcakova E, Fuksa L, Cermanova J, Kolouchova G, Hroch M, Hirsova P, Martinkova J, Staud F, Micuda S (2009) Alteration of methotrexate biliary and renal elimination during extrahepatic and intrahepatic cholestasis in rats. Biol Pharm Bull 32:1978–1985
24. Paigen B, Morrow A, Holmes PA, Mitchell D, Williams RA (1987) Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68:231–240
25. Liao F, Andalibi A, deBeer FC, Fogelman AM, Lusis AJ (1993) Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 91:2572–2579
26. Shi W, Haberland ME, Jien ML, Shih DM, Lusis AJ (2000) Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation 102:75–81
27. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW, Milstone DS (2001) A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107:1255–1262
28. Yano H, Horinaka S, Yagi H, Ishimitsu T (2013) Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in patients on hemodialysis. Heart Vessels 28:308–315
29. Jerkic M, Rodriguez-Barbero A, Prieto M, Toporsian M, Pericacho M, Rivas-Elena JV, Obreo J, Wang A, Perez-Barriocanal F, Arevalo M, Bernabeu C, Letarte M, Lopez-Novoa JM (2006) Reduced angiogenic responses in adult Endoglin heterozygous mice. Cardiovasc Res 69:845–854
30. Dansky HM, Charlton SA, Sikes JL, Heath SC, Simantov R, Levin LF, Shu P, Moore KJ, Breslow JL, Smith JD (1999) Genetic background determines the extent of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 19:1960–1968
31. (−/−) mice despite having a more atherogenic serum lipid profile. Atherosclerosis 151:389–397
32. Forstermann U, Sessa WC (2012) Nitric oxide synthases: regulation and function. Eur Heart J 33:829–837 (pp 837a–837d)